Abstract
Employing a flexible synthetic strategy towards laurenditerpenol, two analogues featuring the 7- oxabicyclo[2.2.1]heptane ring system present in the natural product have been prepared and their ability to inhibit HIF-1 activation has been evaluated. Their weak activity indicates the importance of the cyclohexenol part of the prototype.
Keywords: Furan, Diels-Alder reaction, Olefin cross-metathesis, Natural products
Letters in Organic Chemistry
Title: Synthesis of Novel Laurenditerpenol Analogues and their Evaluation as HIF-1 Activation Inhibitors
Volume: 6 Issue: 4
Author(s): Nikolaos Athinaios, Athanasios Kazantzis, Kerstin Putzker, Joe Lewis and Emmanuel N. Pitsinos
Affiliation:
Keywords: Furan, Diels-Alder reaction, Olefin cross-metathesis, Natural products
Abstract: Employing a flexible synthetic strategy towards laurenditerpenol, two analogues featuring the 7- oxabicyclo[2.2.1]heptane ring system present in the natural product have been prepared and their ability to inhibit HIF-1 activation has been evaluated. Their weak activity indicates the importance of the cyclohexenol part of the prototype.
Export Options
About this article
Cite this article as:
Athinaios Nikolaos, Kazantzis Athanasios, Putzker Kerstin, Lewis Joe and Pitsinos N. Emmanuel, Synthesis of Novel Laurenditerpenol Analogues and their Evaluation as HIF-1 Activation Inhibitors, Letters in Organic Chemistry 2009; 6 (4) . https://dx.doi.org/10.2174/157017809788489891
DOI https://dx.doi.org/10.2174/157017809788489891 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Structure-Activity Relationship Studies on Holy Basil (Ocimum sanctum L.) Based Flavonoid Orientin and its Analogue for Cytotoxic Activity in Liver Cancer Cell Line HepG2
Combinatorial Chemistry & High Throughput Screening Multicomponent Reactions in Antimitotic Drug Discovery
Current Topics in Medicinal Chemistry Matrix Metalloproteinases as Drug Targets in Acute Pulmonary Embolism
Current Drug Targets Synthesis, Design and Anti-inflammatory Activity of Novel 5-(Indol-3- yl)thiazolidinone Derivatives as COX-2 Inhibitors
Letters in Drug Design & Discovery Diversity of Molecular Factors in Alzheimer’s Disease
Current Alzheimer Research Long Non-coding RNA Therapeutics: Recent Advances and Challenges
Current Drug Targets Molecular Mechanisms Regulating mRNA Stability: Physiological and Pathological Significance
Current Genomics Synthesis and In Vitro Biological Activity Evaluation of the Derivatives of Combretastatin A-4
Letters in Drug Design & Discovery Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson’s Disease
Mini-Reviews in Medicinal Chemistry Thyrotoxic Periodic Paralysis: A Concise Review of the Literature
Current Rheumatology Reviews New Ligands of the Tubulin Colchicine Site Based on X-Ray Structures
Current Topics in Medicinal Chemistry Scabies: A Neglected Global Disease
Current Pediatric Reviews D-allose: Molecular Pathways and Therapeutic Capacity in Cancer
Current Molecular Pharmacology Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti- Inflammatory Role for the Cannabinoids
Current Clinical Pharmacology Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease
Current Pharmaceutical Design Chemistry and Biology of Heparin Mimetics that Bind to Fibroblast Growth Factors
Mini-Reviews in Medicinal Chemistry Meet Our Editorial Board Member
Current Topics in Medicinal Chemistry A Comparative QSAR Analysis of Quinazoline Analogues as Tyrosine Kinase (erbB-2) Inhibitors
Medicinal Chemistry Perspectives for Novel Mixed Diruthenium-Organic Drugs as Metallopharmaceuticals in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Phenylpyazoleanilides as a Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 1: A New Class of Orally Available Immunomodulators
Letters in Drug Design & Discovery